✦ LIBER ✦

A phase I study with an expanded cohort to assess the feasibility of intravenous paclitaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with untreated ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group study

✍ Scribed by Natalie Gould; Michael W. Sill; Robert S. Mannel; P.H. Thaker; Paul DiSilvestro; Steve Waggoner; S. Diane Yamada; Deborah K. Armstrong; Lari Wenzel; Helen Huang; Paula M. Fracasso; Joan L. Walker

Book ID: 113963972
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 162 KB
Volume: 125
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2011.12.417

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study with an expanded cohort

A phase I study with an expanded cohort to assess feasibility of intravenous docetaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with previously untreated ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group study

✍ Natalie Gould; Michael W. Sill; Robert S. Mannel; Premal H. Thaker; Paul A. DiSi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 162 KB

A phase I study with an expanded cohort

A phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group study

✍ Mark A. Morgan; Michael W. Sill; Keiichi Fujiwara; Benjamin Greer; Stephen C. Ru 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Phase I feasibility study of intraperito

Phase I feasibility study of intraperitoneal cisplatin and intravenous paclitaxel followed by intraperitoneal paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A gynecologic oncology group study

✍ Don S. Dizon; Michael W. Sill; Natalie Gould; Stephen C. Rubin; S. Diane Yamada; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Phase I feasibility trial of carboplatin

Phase I feasibility trial of carboplatin, paclitaxel, and gemcitabine in patients with previously untreated epithelial ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study

✍ Katherine Y Look; Michael A Bookman; Jessie Schol; Thomas J Herzog; Thomas Rocer 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 128 KB

A phase I trial of dose-dense (biweekly)

A phase I trial of dose-dense (biweekly) carboplatin combined with paclitaxel and pegfilgrastim: A feasibility study in patients with untreated Stage III and IV ovarian, tubal or primary peritoneal cancer: A Gynecologic Oncology Group study

✍ Amy D. Tiersten; Michael W. Sill; Danielle Knight; Franco Muggia; Agustin A. Gar 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 226 KB

STAC: A phase II study of carboplatin/pa

STAC: A phase II study of carboplatin/paclitaxel/bevacizumab followed by randomization to either bevacizumab alone or erlotinib and bevacizumab in the upfront management of patients with ovarian, fallopian tube or peritoneal cancer

✍ S. Campos; T. Atkinson; S. Berlin; M. Roche; C. Whalen; U. Matulonis; N. Horowit 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 48 KB